169 related articles for article (PubMed ID: 10770789)
61. High-level oxacillin and gentamycin resistance with reduced susceptibility to vancomycin in Staphylococcus aureus-carrying mecA and femA gene complex.
Raju S; Kelmani Chandrakanth R; Patil SA
Curr Microbiol; 2007 Jun; 54(6):429-34. PubMed ID: 17457646
[TBL] [Abstract][Full Text] [Related]
62.
Mohammadi-Berenjestanaki H; Khori V; Shirzad-Aski H; Ghaemi EA
Microb Drug Resist; 2020 Mar; 26(3):218-226. PubMed ID: 31424323
[TBL] [Abstract][Full Text] [Related]
63. In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis.
Lozniewski A; Lion C; Mory F; Weber M
J Antimicrob Chemother; 2001 Jan; 47(1):83-6. PubMed ID: 11152435
[TBL] [Abstract][Full Text] [Related]
64. Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci.
Hussain Z; Stoakes L; Massey V; Diagre D; Fitzgerald V; El Sayed S; Lannigan R
J Clin Microbiol; 2000 Feb; 38(2):752-4. PubMed ID: 10655380
[TBL] [Abstract][Full Text] [Related]
65. [Comparative study of the bactericidal activity of cefepime and cefpirome in association with glycopeptides against Staphylococci sensitive and resistant to methicillin].
Husson MO; Fruchart A; Izard D
Pathol Biol (Paris); 1998 Apr; 46(4):279-83. PubMed ID: 9769909
[TBL] [Abstract][Full Text] [Related]
66. In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp.
Yoneda A; Thänert R; Burnham CD; Dantas G
Int J Antimicrob Agents; 2020 Feb; 55(2):105864. PubMed ID: 31870598
[TBL] [Abstract][Full Text] [Related]
67. Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid. Evaluation of oxacillin-resistant and oxacillin-susceptible isolates.
Barry AL
Diagn Microbiol Infect Dis; 1990; 13(5):357-61. PubMed ID: 2282775
[TBL] [Abstract][Full Text] [Related]
68. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.
Mashaly GE; El-Mahdy RH
Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):63. PubMed ID: 28927452
[TBL] [Abstract][Full Text] [Related]
69. Evaluation of fosfomycin combined with vancomycin against vancomycin-resistant coagulase negative staphylococci.
Ibrahim YM; Abu El-Wafa WM
J Chemother; 2020 Dec; 32(8):411-419. PubMed ID: 32372690
[TBL] [Abstract][Full Text] [Related]
70. Staphylococci isolated from animals and food with phenotypically reduced susceptibility to beta-lactamase-resistant beta-lactam antibiotics.
Kaszanyitzky EJ; Egyed Z; Jánosi S; Keseru J; Gál Z; Szabó I; Veres Z; Somogyi P
Acta Vet Hung; 2004; 52(1):7-17. PubMed ID: 15119783
[TBL] [Abstract][Full Text] [Related]
71. Beta-lactam susceptibility of coagulase-negative staphylococci causing catheter sepsis in pediatric patients.
Marcon MJ; Nahata MC; Powell DA; Lisby-Sutch SM
Diagn Microbiol Infect Dis; 1990; 13(1):9-15. PubMed ID: 2331855
[TBL] [Abstract][Full Text] [Related]
72. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Kamimura T; Tawara S; Matsumoto Y; Matsumoto F; Kuwahara S
J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
[TBL] [Abstract][Full Text] [Related]
73. In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains.
Dosler S; Gerceker AA
Chemotherapy; 2011; 57(6):511-6. PubMed ID: 22302084
[TBL] [Abstract][Full Text] [Related]
74. Identification and characterization of methicillin-resistant coagulase-negative staphylococci from bovine mastitis.
Fessler AT; Billerbeck C; Kadlec K; Schwarz S
J Antimicrob Chemother; 2010 Aug; 65(8):1576-82. PubMed ID: 20525989
[TBL] [Abstract][Full Text] [Related]
75. In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.
Shelburne SA; Musher DM; Hulten K; Ceasar H; Lu MY; Bhaila I; Hamill RJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):4016-9. PubMed ID: 15388469
[TBL] [Abstract][Full Text] [Related]
76. Effects of various types of Triton X on the susceptibilities of methicillin-resistant staphylococci to oxacillin.
Suzuki J; Komatsuzawa H; Sugai M; Ohta K; Kozai K; Nagasaka N; Suginaka H
FEMS Microbiol Lett; 1997 Aug; 153(2):327-31. PubMed ID: 9271859
[TBL] [Abstract][Full Text] [Related]
77. Species-specific identification of methicillin resistance in staphylococci.
Petersson AC; Miörner H
Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):206-11. PubMed ID: 7614961
[TBL] [Abstract][Full Text] [Related]
78. In vitro potentiation of ampicillin, oxacillin, norfloxacin, ciprofloxacin, and vancomycin by sanguinarine against methicillin-resistant Staphylococcus aureus.
Obiang-Obounou BW; Kang OH; Choi JG; Keum JH; Kim SB; Mun SH; Shin DW; Park CB; Kim YG; Han SH; Lee JH; Kwon DY
Foodborne Pathog Dis; 2011 Aug; 8(8):869-74. PubMed ID: 21524196
[TBL] [Abstract][Full Text] [Related]
79. [In vitro antibacterial activity of vancomycin in combination with panipenem against carbapenem-resistant MRSA].
Sato S; Miura T; Kudo Y; Kudo E; Saitoh Y; Kimpara I; Tsujino M; Kudo H
Jpn J Antibiot; 1998 Jul; 51(7):488-93. PubMed ID: 9755432
[TBL] [Abstract][Full Text] [Related]
80. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
Kang SL; Rybak MJ
J Antimicrob Chemother; 1997 May; 39 Suppl A():33-9. PubMed ID: 9511060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
